SP 500 Flat as Consumer Stocks Rally Offsets Energy Drag Bruno Mars Matches Taylor Swifts Record on Billboard Radio Songs Chart Extending His Chart Dominance Trump Urges Bank of America JPMorgan to End Alleged Discrimination Against Conservatives Kevin Warsh Takes Over US Fed Amid AIDriven Economic Shift and Persistent Inflation Dollar Weakens on Hormuz Reopening Hopes as Risk Appetite Returns Market Strategies to Consider Amid MemoryChip Rally Fueled by Micron MTNB Q4 2024 Earnings Narrowing Losses Surprise as Biotech Advances Pipeline Without Revenue HRTG Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Persist Autoliv Q1 2026 Earnings EPS Beats Estimates by 66 Stock Rises 2 INBS Q1 2025 Earnings WiderThanExpected Loss as Revenue Remains Absent BGS Q1 2026 Earnings Significant EPS Beat Drives Positive Stock Reaction MESO Q1 2026 Earnings EPS Misses Estimates Amid No Revenue Stock Edges Higher Tejon Ranch TRC Holds Steady Near Support as Modest Gains Continue Global Engine Group Holding Limited GLE Surges 17 Testing Key Resistance at 053 EDD Holds Steady at 550 as Emerging Market Debt Fund Consolidates Near Support Caseys General Stores CASY Slides Over 3 as Resistance Holds Firm SkyWater Technology SKYT Edges Higher as Semiconductor Foundry Stock Tests Key Resistance Treasury Yield Surge Challenges RiskFree Label Shifts Focus to Intermediate and Corporate Bonds EWCZ Q4 2025 Earnings Strong Earnings Beat as Cost Discipline Drives Profitability Surprise EVI Industries Faces Pressure Stock Declines on Volume Eyes Key Support Levels RenovoRx Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline ACHV Q1 2026 Earnings EPS Surprises with Smaller Loss Despite No Revenue BCE Q1 2026 Earnings EPS Surprises to the Upside Shares Rise 218 KTOS Q1 2026 Earnings EPS Beats Estimates as Defense Tech Momentum Drives Stock Surge FOA Q1 2026 Earnings Strong EPS Surprise of 2966 Drives Investor Attention ENLT Q1 2026 Earnings Positive EPS Surprise Drives Modest Stock Gain CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase